Journal article
Association between Oncologic Drugs Advisory Committee (ODAC) members’ financial conflicts of interest (FCOIs) and recommendations for drug approval by the U.S. Food and Drug Administration (FDA).
- Tibau Martorell, Ariadna Hospital de la Santa Creu i Sant Pau, Barcelona, YT, Spain
- Ocana, Alberto Hospital General Universitario De Albacete, Barcelona, Spain
- Seruga, Bostjan Institute of Oncology Ljubljana, Ljubljana, Slovenia
- Templeton, Arnoud J. Kantonsspital St Gallen, St Gallen, Switzerland
- Barnadas, Agusti Hospital Sant Pau, Barcelona, Spain
- Amir, Eitan Division of Medical Oncology & Hematology, Princess Margaret Cancer Center, Toronto, ON, Canada
Published in:
- Journal of Clinical Oncology. - American Society of Clinical Oncology (ASCO). - 2015, vol. 33, no. 15_suppl, p. 6582-6582
- Language
-
- English
- Open access status
- closed
- Identifiers
-
- DOI 10.1200/jco.2015.33.15_suppl.6582
- ISSN 0732-183X
- Persistent URL
- https://sonar.ch/global/documents/280944
Statistics
Document views: 14
File downloads: